Federal grants to Siolta Therapeutics Inc
Siolta Therapeutics Inc in San Carlos, California received $3.8 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Allergy and Infectious Diseases Research, with $3.8 million. In fiscal 2025 it was awarded $529,498.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$3.8 million
- Awards3
- Awarded in FY 2025$529,498
- Largest award$2.9 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 0 | $0 |
| FY 2022 | 1 | $979,061 |
| FY 2023 | 2 | $1.3 million |
| FY 2024 | 1 | $948,833 |
| FY 2025 | 1 | $529,498 |
Programs that fund Siolta Therapeutics Inc
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $3.8 million |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 3 | $3.8 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| Anaerobic manufacturing and molecular analytical process optimization to support clinical development of live biotherapeutic products - abstract allergic diseases including atopic dermatitis, food allergy, and allergic asthma represent a global health problem that disproportionately impacts children | Allergy and Infectious Diseases Research | February 3, 2022 | $2.9 million |
| Development of a multispecies live biotherapeutic product for the prevention of recurrent bacterial vaginosis - abstract recurrent bacterial vaginosis (RBV) is the most common vaginal disorder among women of reproductive age and is caused by a loss of protective lactobacillus bacteria and overgrowth | Allergy and Infectious Diseases Research | August 5, 2025 | $529,498 |
| A synergistic multistrain live biotherapeutic product for the prevention and treatment of necrotizing enterocolitis - abstract necrotizing enterocolitis (NEC) is an inflammatory disease of the intestines that primarily afflicts preterm infants. In severe cases, intestinal tissue necrosis can lead to | Allergy and Infectious Diseases Research | August 14, 2023 | $300,000 |
Questions people ask
How much federal grant money does Siolta Therapeutics Inc get?
$3.8 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Siolta Therapeutics Inc the most?
The Department of Health and Human Services, with $3.8 million in 3 awards.
What is Siolta Therapeutics Inc's largest federal grant?
$2.9 million under Allergy and Infectious Diseases Research, with its first action in the period on February 3, 2022. That counts only the money obligated in fiscal 2021 to 2025.
Other grant recipients in San Carlos
- Peninsula Corridor Joint Powers Board
- San Mateo County Transit District
- Swift Solar Inc
- Ihp Therapeutics Inc
- Village Enterprise Fund, Inc.
- Dorian Therapeutics Inc
- Onc.ai, Inc.
- Envivo Bio Inc
Largest federal grant recipients in California · Federal grants in California